Pharma News
Johnson & Johnson Reports Promising Findings for Xarelto for the Treatment of Clinically Significant Bleeding
![](https://meefro.com/wp-content/uploads/2024/04/Johnson-amp-Johnson-Reports-Promising-Findings-for-Xarelto-for-the-780x470.png)
PIONEER AF-PCI exploratory trial found that elderly patients experienced a lower rate of clinically significant bleeding after 12 months of treatment with Xarelto (rivaroxaban).
Source link
#Johnson #amp #Johnson #Reports #Promising #Findings #Xarelto #Treatment #Clinically #Significant #Bleeding